Austral Capital

Austral Capital is a venture capital firm that specializes in investing in technology and life sciences companies across Latin America, particularly in Chile, Colombia, Peru, and Mexico. The firm targets growth-stage enterprises that are positioned to expand their service and solution offerings, with a focus on sectors such as financial services, retail, and healthcare. By concentrating on highly specialized industries, Austral Capital aims to support companies that demonstrate potential for profitability and sustainability, fostering innovation and development in the region.

Felipe Camposano

General Partner

Fernando Diaz

Chief Operating Officer

Jorge Leyton

Chief Financial Officer

Nicolas Zarges

Principal

9 past transactions

Andes Biotechnologies

Venture Round in 2014
Andes Biotechnologies S.A., a biotechnology company, engages in the research, development, and marketing of anti-cancer drugs and therapies in the United States and Europe. It develops solutions based on the RNA targets of mitochondrial origin, which selectively destroy cancer cells without affecting normal cells. The company was founded in 2010 and is based in Santiago, Chile.

Scopix

Venture Round in 2012
SCOPIX is the market leader in intelligent video analytics for retailers, CPG companies and manufactures. Our Real.Suite ™ family of cloud based solutions collects data and returns timely, actionable information via a web based portal to store personnel, regional managers and corporate executives to help them maximize the customer experience throughout the entire store. SCOPIX solutions are proven to enhance retail business operations, drive sales and maximize profits.

Junar

Seed Round in 2012
Junar powers the Data Economy by delivering the easiest-to-use, cloud-based Open Data platform. For innovative organizations, Junar is the fastest way to publish data. The Junar platform enables businesses, governments, and organizations to free their data to drive new opportunities, collaboration, and transparency. Some of the world's leading companies trust Junar with their most valuable assets: their data and the end users who are viewing and using it.

Nimbic

Venture Round in 2012
Nimbic is a provider of SaaS-based, cloud computing electronic design automation (EDA) solutions. Nimbic enables high-speed and high-capacity 3D electromagnetic signal integrity, power integrity and EMI analysis field solutions for the microelectronics industry. Nimbic's global customers include Texas Instruments, Renesas, Toshiba, Tabula and Panasonic. Nimbic's nCloud solution facilitates efficient and robust chip-package-system co-design while significantly reducing time-to-market and costs. Nimbic's accelerated technology delivers unprecedented capacity handling, significantly faster speed than current methodologies, and the ability to span the entire design cycle in 3D IC, package and system simulations, while maintaining uncompromising Maxwell accuracy.

Nimbic

Series B in 2011
Nimbic is a provider of SaaS-based, cloud computing electronic design automation (EDA) solutions. Nimbic enables high-speed and high-capacity 3D electromagnetic signal integrity, power integrity and EMI analysis field solutions for the microelectronics industry. Nimbic's global customers include Texas Instruments, Renesas, Toshiba, Tabula and Panasonic. Nimbic's nCloud solution facilitates efficient and robust chip-package-system co-design while significantly reducing time-to-market and costs. Nimbic's accelerated technology delivers unprecedented capacity handling, significantly faster speed than current methodologies, and the ability to span the entire design cycle in 3D IC, package and system simulations, while maintaining uncompromising Maxwell accuracy.

Andes Biotechnologies

Venture Round in 2011
Andes Biotechnologies S.A., a biotechnology company, engages in the research, development, and marketing of anti-cancer drugs and therapies in the United States and Europe. It develops solutions based on the RNA targets of mitochondrial origin, which selectively destroy cancer cells without affecting normal cells. The company was founded in 2010 and is based in Santiago, Chile.

Bio Architecture Lab

Series A in 2009
Bio Architecture Lab is a pioneer in the application of synthetic biology and enzyme design to the development of biofuels and renewable chemicals from aquafarmed, native macroalgae (seaweed), which is a low cost, scalable, and sustainable biomass.

Atakama Labs

Seed Round in 2009
Atakama Labs is a developer, publisher and operator of social games, focused on meaningful games. They are making games that will make the world a better place, while entertaining and surprising their players. Their games tend to be free to play so that everyone can enjoy them. They develop primarily in Chile and publish their products across the globe, both directly and together with partners, depending on the platform and territory. Atakama is backed by Austral Capital and the COPEC-UC Fund, two venture capital funds.

Paperless

Series A in 2008
Paperless is an electronic receipts and electronic document management company in Latin America, processing over two billion documents per year for global enterprise businesses.